Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ·Healthcare·Biotechnology
$500.10
-0.22%
Mkt Cap $11.56B
Analyst Ratings
Buy
5
Hold
2
Sell
0
Price Target (31 analysts)
$705.67
Range $527.00 – $964.00
Implied Upside
+41.1%
Consensus $705.67 vs current $500.10